7 Mar 2025
📉Executive Order Raises Tariffs on Chinese Imports for Opioid Crisis
Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China
Summary
Executive Order 14228 addresses the ongoing threat posed by synthetic opioids, specifically from China. The order amends previous executive actions and increases tariffs on related products, citing insufficient action by the PRC to mitigate this issue. The measure emphasizes national security concerns linked to drug trafficking and economic stability.
Agencies
- Executive Office of the President
Business Impact
$$$ - High
The executive order increases tariffs on certain products from the PRC to address the illicit drug crisis, which affects businesses importing these goods. Higher tariffs (from 10% to 20%) could lead to increased costs for businesses relying on imports from China, impacting pricing strategies and profit margins.